Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rescue alkaline phosphatase for acute kidney injury
NL-OMON51165Phase 2Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2022
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in acute kidney failure (AKF) comparing bRESCAP with placebo (2 arms). Primary endpoint: Proportion developing acute kidney disease combined with 90-day mortality. Started Apr 2022; status: active, not recruiting.
02
Drugs
bovine intestinal alkaline phosphatase
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on NL-OMON51165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51165.